Valuation: BioAdaptives, Inc.

Market Cap 43.03K 37.17K 34.97K 31.78K 59.77K 4.12M 60.65K 410K 161K 2.06M 162K 158K 6.87M P/E 2024
-0.55x
P/E 2025 -0.14x
Enterprise Value 269K 232K 219K 199K 374K 25.78M 379K 2.56M 1M 12.89M 1.01M 988K 42.94M EV / Sales 2024
55.1x
EV / Sales 2025 26.9x
Free-Float
82.58%
Yield 2024 *
-
Yield 2025 -
1 week+50.00%
Current month-58.42%
1 month+68.75%
3 months-75.45%
6 months-84.73%
Current year-87.78%
1 week 0
Extreme 0.0014
0
1 month 0
Extreme 0.001055
0.01
Current year 0
Extreme 0.0008
0.03
1 year 0
Extreme 0.0008
0.07
3 years 0
Extreme 0.0008
0.9
5 years 0
Extreme 0.0008
7.28
10 years 0
Extreme 0.0008
108
Manager TitleAgeSince
Chief Executive Officer 55 2024-05-20
Investor Relations Contact - -
Corporate Officer/Principal 63 -
Director TitleAgeSince
Director/Board Member 53 2024-05-29
Chairman 55 2024-05-20
Director/Board Member 70 2025-02-02
Date Insider Type Main position Quantity % Market Cap.
2/15/25 Buy

Director

1 0.0000%
11/22/24 Buy

Director

125,000 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+50.00%-89.29%-99.31% 43.03K
+1.26%-4.61%+26.20%+80.57% 13.2B
-0.09%+2.52%-13.30%+331.42% 9.17B
-1.10%-0.90%-19.85%-48.86% 2.46B
+5.09%+3.25%-15.88%-7.19% 1.5B
+0.02%-0.31%+26.73%+78.09% 1.36B
+2.92%+5.11%+34.57%-20.03% 1.29B
+1.96%-10.13%-73.03%-72.76% 1.21B
+0.37%-2.24%-39.02% - 1.11B
+1.20%+1.01%-61.25%-68.68% 970M
Average +1.16%+3.91%-22.41%+19.25% 3.23B
Weighted average by Cap. +0.88%-1.55%+1.29%+125.10%

Financials

2024 2025
Net sales 12.67K 10.94K 10.3K 9.36K 17.6K 1.21M 17.86K 121K 47.33K 607K 47.57K 46.53K 2.02M 18.28K 15.79K 14.85K 13.5K 25.39K 1.75M 25.76K 174K 68.28K 876K 68.62K 67.14K 2.92M
Net income -899K -777K -731K -664K -1.25M -86.15M -1.27M -8.57M -3.36M -43.09M -3.38M -3.3M -144M -1.56M -1.35M -1.27M -1.15M -2.16M -149M -2.2M -14.85M -5.82M -74.66M -5.85M -5.72M -249M
Net Debt 206K 178K 167K 152K 286K 19.7M 290K 1.96M 768K 9.85M 772K 755K 32.82M 226K 195K 184K 167K 314K 21.65M 319K 2.15M 844K 10.83M 848K 830K 36.07M
Logo BioAdaptives, Inc.
BioAdaptives, Inc. operates in the health and wellness industry. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.
Employees
1
Date Price Change Volume
26-08-18 US$0.002700 0.00% 30,086,110
26-08-17 US$0.002700 +65.14% 75,939,776
26-08-14 US$0.001635 -0.61% 12,979,554
26-08-13 US$0.001645 +2.81% 48,780,153
26-08-12 US$0.001600 -11.11% 57,212,536
  1. Stock Market
  2. Stocks
  3. BDPT Stock